Vascular Biogenics
AcquiredVBL Therapeutics
Public · Yehud, Israel · Founded 2000 · $30.9M raised
- Total Funding
- $30.9M
- Last Round
- $2.5M GrantOct 2021
- Rounds
- 2
- Type
- Public
- Acquisition Date
- Feb 2023
About
Israeli clinical-stage biopharmaceutical company developing targeted gene therapies and small molecule drugs for immune-inflammatory diseases; trades on Nasdaq as VBLT.
Summary
Vascular Biogenics is a Biotech company based in Yehud, Israel, founded in 2000. It has raised $30.9M in total across 2 rounds, most recently a $2.5M Grant round in Oct 2021. Investors include European Innovation Council Fund and ROTH Capital Partners.
Tech & App Stack
1 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Feb 2023
Sign up to see all 4 rounds
IPO through Acquisition — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/vascular-biogenics"><img src="https://indexed.vc/api/badge/company/vascular-biogenics" alt="Vascular Biogenics on Indexed.vc" width="260" height="76" /></a>